Abnormal fluid retention
Conditions
Interventions
Additional administration of Goreisan 7.5g/day on intravenous injection of diuretics for abnormal fluid retention.
Intravenous injection of diuretics for abnormal fluid retention.
Sponsors
Tokorozawa Heart Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who need intravenous injection of diuretics due to abnormal fluid retention. 2) Patients who gave written informed consent
Exclusion criteria
Exclusion criteria: 1) Patients younger than 20 years old 2) Patients who have allergy for cinnamon 3) Patients who are pregnant or hope to be pregnant 4) Patients who cannot take oral administration 5) Patients who have no urination due to end-stage renal failure on hemodialysis 6) Patients who are not expected to react to diuretics due to acute kidney injury 7) Patients who participate in another interventional trial 8) Patients whose doctor in charge do not agree to join the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A total of 3days urine volume form the day after participation in this study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum creatinine, electrolyte, liver enzyme, body weight, and the degree of peripheral edema. | — |
Countries
Japan
Contacts
Public ContactHirotaka Ezaki
Tokorozawa Heart Center Department of Cardiology
Outcome results
None listed